Last updated 2026-09-02
- Raised $14k grant led by BizTEC, Jul 2025
- Raised $351k grant led by Reichman University, 2025
Total raised
$365K
Last: Grant 2025-07
Stage
Pre-Funding
Founded
2025
Headcount
2
HQ
Haifa, Israel
Sector
Biotechnology
About
FiBreath is a patent-protected platform that partners with pharmaceutical companies to deliver complex biologics and acute crisis treatments directly through the deep lung, achieving therapeutic onset in minutes. The technology utilizes engineered fiber particles designed for deep-lung penetration, bypassing the throat and upper airways. FiBreath aims to streamline clinical trials by potentially lowering required doses, leading to fewer side effects, faster metabolic clearance, and predictable clinical outcomes. The company positions itself at the intersection of delivery science and pharma commercial demand, targeting the global inhaled biologics market.
Funding history · 2 rounds · $365K total
2 events/rounds · $365K Total Funding
Jul 2025
★ BizTEC★ Bronica Entrepreneurship Center at the Technion
2025
★ Reichman University★ Israel Innovation Authority★ Technion Innovation and Entrepreneurship Hub (t:hub)
Offices
Haifa, Israel · HQ / main office
Q&A
- What is FiBreath's primary focus?
- FiBreath is developing a novel inhaled-therapy platform designed for deep-lung delivery to address the global burden of respiratory disease, specifically targeting asthma and COPD patients.
- When was FiBreath founded?
- FiBreath was founded in July 2025.
- What is FiBreath's business model?
- FiBreath's business model focuses on licensing its platform to leading pharmaceutical and inhaler manufacturers in exchange for royalties.
- What is FiBreath's current funding stage?
- FiBreath is currently in the Pre-Funding stage.
- Who are the founders of FiBreath?
- The founders of FiBreath are Hai Zaguri (CEO) and Ron Bessler (CTO).
- What is the total amount of funding FiBreath has raised?
- FiBreath has raised a total of $9,000 USD.
- Which investor participated in FiBreath's Grant round?
- BizTEC participated in FiBreath's Grant round in July 2025.
Team · 5
Hay Zagory
Founder · Co-Founder & CEO
Dr. Ron Bessler
Founder · CTO & Co-Founder
Mark Milton-Edwards
Advisory Board
Prof. Josue Sznitman
Advisory Board
Dr. Moshe Ashkenazi, MD
Advisory Board
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
B2BPlatform-as-a-Service
Highlights
Verified
Tags
inhalationasthmarespiratorystealthmodedrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fibreath.com |
|---|---|
| linkedin.com/company/107954894 |
Identifiers & details
| Founded | 2025-7 |
|---|---|
| Employees (exact) | 2 |
Radar intelligence
Web history (Wayback)
| Domain | fibreath.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|